Patents by Inventor Devapregasan MOODLEY

Devapregasan MOODLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-IL-27 antibodies and uses thereof
    Patent number: 12630624
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Grant
    Filed: April 6, 2022
    Date of Patent: May 19, 2026
    Assignee: SURFACE ONCOLOGY, LLC
    Inventors: Jonathan Hill, Scott Chappel, Michael Gladstone, Bianka Prinz, Andrew Lake, Christine Miller, Kerry White, Jing Hua, Pamela M. Holland, Matthew Rausch, Devapregasan Moodley
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20260055176
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: June 12, 2025
    Publication date: February 26, 2026
    Applicant: Surface Oncology, LLC
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY, Gege TAN
  • CELL THERAPIES FOR MULTIPLE SCLEROSIS
    Publication number: 20260034215
    Abstract: The present disclosure is directed to isolated cell populations comprising stable regulatory T cells and methods of producing the same.
    Type: Application
    Filed: February 11, 2025
    Publication date: February 5, 2026
    Inventors: Stephen SOFEN, Andrea VAN ELSAS, Richard RANSOHOFF, Devapregasan MOODLEY, Jefte DRIJVERS, Eugene ANTIPOV, Michael BIRNBAUM, Lawrence SCHWEITZER, Enoch KISUBIKA, Christina STRANGE, Fang XIA, Harish ADONI, Yanbo ZHANG
  • CELL THERAPIES FOR TYPE 1 DIABETES
    Publication number: 20250295772
    Abstract: The present disclosure is directed to T cell receptors targeting proinsulin and isolated cell populations comprising regulatory T cells exogenously expressing the T cell receptors used to treat Type 1 Diabetes.
    Type: Application
    Filed: June 5, 2025
    Publication date: September 25, 2025
    Inventors: Geetha MYLVAGANAM, Devapregasan MOODLEY, Jeremy BURNS, Yanbo ZHANG, Timothy NELSON
  • REGULATORY T CELL STABILITY ASSAY
    Publication number: 20250258162
    Abstract: The present disclosure is directed, in some aspects to methods and compositions for the assessment of regulatory T cell stability over time. In other aspects, the present disclosure provides methods and compositions for expanding regulatory T cells in culture.
    Type: Application
    Filed: April 17, 2025
    Publication date: August 14, 2025
    Inventors: Yanbo ZHANG, Devapregasan MOODLEY
  • Anti-IL-27 antibodies and uses thereof
    Patent number: 12358978
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: July 15, 2025
    Assignee: SURFACE ONCOLOGY, LLC
    Inventors: Jonathan Hill, Scott Chappel, Michael Gladstone, Bianka Prinz, Andrew Lake, Christine Miller, Kerry White, Jing Hua, Pamela M. Holland, Matthew Rausch, Devapregasan Moodley, Gege Tan
  • STABLE REGULATORY T CELLS AND METHODS OF PRODUCTION
    Publication number: 20250186497
    Abstract: The present disclosure is directed to isolated cell populations comprising stable regulatory T cells and methods of producing the same.
    Type: Application
    Filed: February 11, 2025
    Publication date: June 12, 2025
    Inventors: Stephen SOFEN, Andrea VAN ELSAS, Richard RANSOHOFF, Devapregasan MOODLEY, Yanbo ZHANG, Jefte DRIJVERS, Eugene ANTIPOV, Harish ADONI, Fang XIA, Enoch KISUBIKA, Christina STRANGE
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20250154244
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 15, 2025
    Applicant: SURFACE ONCOLOGY, LLC
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20230042258
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: April 6, 2022
    Publication date: February 9, 2023
    Applicants: Surface Oncology, Inc., Adimab LLC
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20220259299
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: September 25, 2019
    Publication date: August 18, 2022
    Applicant: SURFACE ONCOLOGY, INC.
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY, Gege TAN
  • Anti-IL-27 antibodies and uses thereof
    Patent number: 11332524
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: May 17, 2022
    Assignees: Surface Oncology, Inc., Adimab LLC
    Inventors: Jonathan Hill, Scott Chappel, Michael Gladstone, Bianka Prinz, Andrew Lake, Christine Miller, Kerry White, Jing Hua, Pamela M. Holland, Matthew Rausch, Devapregasan Moodley
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20190382474
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: March 22, 2019
    Publication date: December 19, 2019
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY